![]() | ![]() | Log on / register BioMed Central home | Journals A-Z | Feedback | Support | My details |
home | issues | articles | reports | supplements | weblinks | conferences | search | information | subscribe | my details |
| Review seriesHER2 therapyEdited by Mark Pegram
Review
![]() ![]() HER-2 therapy. HER-2/neu diagnostics in breast cancer Walter P Carney, Kim Leitzel, Suhail Ali, Rainer Neumann, Allan Lipton Breast Cancer Research 2007, 9:207 (4 June 2007) [Abstract] [Full text] [PDF] [PubMed] [Related articles] Review ![]() HER2 therapy. Small molecule HER-2 tyrosine kinase inhibitors Neil Spector, Wenle Xia, Iman El-Hariry, Yossi Yarden, Sarah Bacus Breast Cancer Research 2007, 9:205 (2 March 2007) [Abstract] [Full text] [PDF] [PubMed] [Related articles] Review ![]() HER2 therapy. HER2 (ERBB2): functional diversity from structurally conserved building blocks Ralf Landgraf Breast Cancer Research 2007, 9:202 (22 January 2007) [Abstract] [Full text] [PDF] [PubMed] [Related articles] Review ![]() ![]() HER2 therapy: Molecular mechanisms of trastuzumab resistance Rita Nahta, Francisco J Esteva Breast Cancer Research 2006, 8:215 (6 November 2006) [Abstract] [Full text] [PDF] [PubMed] [Related articles] | ![]() | ||
|
|
| © 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media. |